Mindray announces definitive agreement to acquire remaining stake in Dragonbio for US$72.6 million

Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitive agreement to acquire the remaining stake in Wuhan Dragonbio Surgical Implant Co., Ltd. ("Dragonbio") for approximately US$72.6 million.

Dragonbio is a domestic medical orthopedic-product provider that specializes in trauma, spine, joint and other surgical products. Prior to today's announcement, Mindray already has a controlling stake of Dragonbio, which was acquired in 2012. The transaction will be funded through Mindray's existing cash reserves and is expected to close in July. Mindray expects the deal to have non-material impact on its 2015 financial results.

"Since we acquired a majority stake of Dragonbio in 2012, the integration has been well on track," said Mr. Minghe Cheng, Mindray's Co-Chief Executive Officer and Chief Strategic Officer. "We are optimistic about the prospects of the orthopedic consumable market in China and have therefore decided to make Dragonbio our wholly owned subsidiary. The transaction is expected to help us manage and expand the business more efficiently and effectively through our strong capital position, large-scale operational experience and worldwide presence."

Source:

Mindray

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mindray. (2019, June 24). Mindray announces definitive agreement to acquire remaining stake in Dragonbio for US$72.6 million. News-Medical. Retrieved on August 06, 2020 from https://www.news-medical.net/news/20150707/Mindray-announces-definitive-agreement-to-acquire-remaining-stake-in-Dragonbio-for-US24726-million.aspx.

  • MLA

    Mindray. "Mindray announces definitive agreement to acquire remaining stake in Dragonbio for US$72.6 million". News-Medical. 06 August 2020. <https://www.news-medical.net/news/20150707/Mindray-announces-definitive-agreement-to-acquire-remaining-stake-in-Dragonbio-for-US24726-million.aspx>.

  • Chicago

    Mindray. "Mindray announces definitive agreement to acquire remaining stake in Dragonbio for US$72.6 million". News-Medical. https://www.news-medical.net/news/20150707/Mindray-announces-definitive-agreement-to-acquire-remaining-stake-in-Dragonbio-for-US24726-million.aspx. (accessed August 06, 2020).

  • Harvard

    Mindray. 2019. Mindray announces definitive agreement to acquire remaining stake in Dragonbio for US$72.6 million. News-Medical, viewed 06 August 2020, https://www.news-medical.net/news/20150707/Mindray-announces-definitive-agreement-to-acquire-remaining-stake-in-Dragonbio-for-US24726-million.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Mindray Medical announces completion of Wuhan Dragonbio acquisition